Emmanuel E. Egom

1.6k total citations
56 papers, 1.1k citations indexed

About

Emmanuel E. Egom is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Emmanuel E. Egom has authored 56 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cardiology and Cardiovascular Medicine, 22 papers in Molecular Biology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Emmanuel E. Egom's work include Sphingolipid Metabolism and Signaling (15 papers), Heart Failure Treatment and Management (12 papers) and Cardiovascular Function and Risk Factors (8 papers). Emmanuel E. Egom is often cited by papers focused on Sphingolipid Metabolism and Signaling (15 papers), Heart Failure Treatment and Management (12 papers) and Cardiovascular Function and Risk Factors (8 papers). Emmanuel E. Egom collaborates with scholars based in Canada, Ireland and United Kingdom. Emmanuel E. Egom's co-authors include Ming Lei, Peter Kružliak, Mamas A. Mamas, Robert A. Rose, Motahareh Moghtadaei, Hailey J. Jansen, Yunbo Ke, R. John Solaro, Martin Mackasey and Sara A. Rafferty and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Emmanuel E. Egom

53 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emmanuel E. Egom Canada 21 527 433 146 138 85 56 1.1k
Subhash K. Das Canada 19 591 1.1× 412 1.0× 311 2.1× 116 0.8× 37 0.4× 27 1.4k
Bin Kong China 20 342 0.6× 368 0.8× 74 0.5× 88 0.6× 32 0.4× 62 968
Ke‐Qiong Deng China 16 249 0.5× 372 0.9× 86 0.6× 38 0.3× 77 0.9× 32 787
Hesong Zeng China 16 157 0.3× 275 0.6× 84 0.6× 87 0.6× 41 0.5× 38 732
Raffaele Altara United States 20 374 0.7× 277 0.6× 131 0.9× 66 0.5× 25 0.3× 45 1.0k
Carole S. Frye United States 10 785 1.5× 572 1.3× 105 0.7× 46 0.3× 43 0.5× 11 1.3k
Sandip Chaugai China 17 261 0.5× 557 1.3× 102 0.7× 55 0.4× 21 0.2× 22 1.0k
Carmine Del Giudice Italy 17 267 0.5× 427 1.0× 110 0.8× 52 0.4× 43 0.5× 24 1.0k
Natsuya Keira Japan 15 394 0.7× 288 0.7× 157 1.1× 85 0.6× 29 0.3× 66 917
Juan Pablo Arroyo United States 16 186 0.4× 652 1.5× 128 0.9× 361 2.6× 34 0.4× 44 1.2k

Countries citing papers authored by Emmanuel E. Egom

Since Specialization
Citations

This map shows the geographic impact of Emmanuel E. Egom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel E. Egom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel E. Egom more than expected).

Fields of papers citing papers by Emmanuel E. Egom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel E. Egom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel E. Egom. The network helps show where Emmanuel E. Egom may publish in the future.

Co-authorship network of co-authors of Emmanuel E. Egom

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel E. Egom. A scholar is included among the top collaborators of Emmanuel E. Egom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel E. Egom. Emmanuel E. Egom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Egom, Emmanuel E., et al.. (2024). Unveiling the subconscious: How sexual dreams reflect and intensify mental problems. SHILAP Revista de lepidopterología. 2(1). 13–22.
2.
Shiwani, Haaris A., et al.. (2022). COVID-19 and myocarditis: a review of literature. The Egyptian Heart Journal. 74(1). 23–23. 30 indexed citations
3.
Qaradakhi, Tawar, Laura Kate Gadanec, Kristen Renee McSweeney, et al.. (2020). The potential actions of angiotensin‐converting enzyme II (ACE2) activator diminazene aceturate (DIZE) in various diseases. Clinical and Experimental Pharmacology and Physiology. 47(5). 751–758. 77 indexed citations
4.
Čaprnda, Martin, Peter Kubatka, Andreja Sinkovič, et al.. (2018). Markers of Atherosclerosis: Part 1 – Serological Markers. Heart Lung and Circulation. 28(5). 667–677. 52 indexed citations
5.
Čaprnda, Martin, Peter Kubatka, Andreja Sinkovič, et al.. (2018). Markers of Atherosclerosis: Part 2 – Genetic and Imaging Markers. Heart Lung and Circulation. 28(5). 678–689. 37 indexed citations
6.
Jansen, Hailey J., Martin Mackasey, Motahareh Moghtadaei, et al.. (2018). Distinct patterns of atrial electrical and structural remodeling in angiotensin II mediated atrial fibrillation. Journal of Molecular and Cellular Cardiology. 124. 12–25. 53 indexed citations
7.
Egom, Emmanuel E., et al.. (2017). NEW INSIGHTS AND NEW HOPE FOR PULMONARY ARTERIAL HYPERTENSION: NATRIURETIC PEPTIDES CLEARANCE RECEPTOR AS A NOVEL THERAPEUTIC TARGET FOR A COMPLEX DISEASE. Journal of the American College of Cardiology. 69(11). 1902–1902. 11 indexed citations
8.
9.
Kružliak, Peter, Alexander Е. Berezin, Alexander A. Kremzer, et al.. (2016). Global Longitudinal Strain and Strain Rate in Type Two Diabetes Patients with Chronic Heart Failure: Relevance to Osteoprotegerin. Folia Medica. 58(3). 164–173. 5 indexed citations
10.
Egom, Emmanuel E., et al.. (2016). Biochemistry of Statins. Advances in clinical chemistry. 73. 127–168. 40 indexed citations
11.
Egom, Emmanuel E., Rebecca A. Capel, Mark Richards, et al.. (2016). Effect of sphingosine-1-phosphate on L-type calcium current and Ca2+ transient in rat ventricular myocytes. Molecular and Cellular Biochemistry. 419(1-2). 83–92. 13 indexed citations
12.
Egom, Emmanuel E.. (2015). BNP and Heart Failure: Preclinical and Clinical Trial Data. Journal of Cardiovascular Translational Research. 8(3). 149–157. 19 indexed citations
13.
Egom, Emmanuel E., Mamas A. Mamas, & Handrean Soran. (2013). HDL quality or cholesterol cargo. Current Opinion in Lipidology. 24(4). 351–356. 22 indexed citations
14.
Egom, Emmanuel E.. (2013). Sphingosine-1-phosphate signalling as a therapeutic target for patients with abnormal glucose metabolism and ischaemic heart disease. Journal of Cardiovascular Medicine. 15(7). 517–524. 4 indexed citations
15.
Egom, Emmanuel E., Mamas A. Mamas, Sanoj Chacko, et al.. (2013). Serum sphingolipids level as a novel potential marker for early detection of human myocardial ischaemic injury. Frontiers in Physiology. 4. 130–130. 53 indexed citations
16.
Egom, Emmanuel E., Mamas A. Mamas, & Andrew L. Clark. (2012). The potential role of sphingolipid-mediated cell signaling in the interaction between hyperglycemia, acute myocardial infarction and heart failure. Expert Opinion on Therapeutic Targets. 16(8). 791–800. 24 indexed citations
17.
Egom, Emmanuel E., et al.. (2011). A review of thiazide-induced hyponatraemia. Clinical Medicine. 11(5). 448–451. 15 indexed citations
18.
Egom, Emmanuel E., Mamas A. Mamas, Simi Chacko, et al.. (2010). Serum Sphingolipids Level as a Novel Potential Indicator for Early Detection of Cardiac Ischemia. Circulation. 122. 1 indexed citations
19.
Egom, Emmanuel E., Yunbo Ke, R. John Solaro, & Ming Lei. (2010). Cardioprotection in ischemia/reperfusion injury: Spotlight on sphingosine-1-phosphate and bradykinin signalling. Progress in Biophysics and Molecular Biology. 103(1). 142–147. 17 indexed citations
20.
Egom, Emmanuel E., Yunbo Ke, Hanny Musa, et al.. (2009). FTY720 prevents ischemia/reperfusion injury-associated arrhythmias in an ex vivo rat heart model via activation of Pak1/Akt signaling. Journal of Molecular and Cellular Cardiology. 48(2). 406–414. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Subhash K. Das Breakdown of academic impact, for papers by Bin Kong Breakdown of academic impact, for papers by Ke‐Qiong Deng Breakdown of academic impact, for papers by Hesong Zeng Breakdown of academic impact, for papers by Raffaele Altara Breakdown of academic impact, for papers by Carole S. Frye Breakdown of academic impact, for papers by Sandip Chaugai Breakdown of academic impact, for papers by Carmine Del Giudice Breakdown of academic impact, for papers by Natsuya Keira Breakdown of academic impact, for papers by Juan Pablo Arroyo
Rankless by CCL
2026